SCA
XLRN

Sassicaia Capital Advisers’s Acceleron Pharma XLRN Stock Holding History

Sassicaia Capital Advisers’s Portfolio XLRN Stock Details XLRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-3,800
Closed -$654K – 53
2021
Q3 		$654K Buy
+3,800
New +$497K 1.85% 16

Sassicaia Capital Advisers's XLRN Position: Q4 2021 in Review

Sassicaia Capital Advisers sold out of Acceleron Pharma (XLRN) in Q4 2021, closing a stake of 3,800 shares — an estimated $654K sold.

Sassicaia Capital Advisers first reported a position in XLRN in Q3 2021 and held it in 1 quarter. The position peaked at $654K in Q3 2021. 1 fund tracked by Wall St. Rank holds XLRN as of Q4 2021.

  • Sassicaia Capital Advisers reported no remaining Acceleron Pharma position as of Q4 2021 after selling out during the quarter.
  • Sassicaia Capital Advisers sold 3,800 Acceleron Pharma shares in Q4 2021, an estimated $654K.
  • Sassicaia Capital Advisers first reported a position in Acceleron Pharma in Q3 2021 and held it in 1 quarter.
  • Sassicaia Capital Advisers's Acceleron Pharma position peaked at $654K in Q3 2021.
  • 1 fund tracked by Wall St. Rank held Acceleron Pharma as of Q4 2021.

Based on Sassicaia Capital Advisers's 13F filing for Q4 2021, filed 14 Feb 2022.